Contrast media radiography in patients with retrosternal irrigation drainage for severe sternal wound infection.
Severe wound infection after open-heart surgery is a potentially life-threatening complication, which is mostly treated by re-operation with debridement, and insertion of closed irrigation drainage. Until now there is no consensus about the appropriate duration of irrigation therapy. Since the retrosternal irrigation cavity is likely to become continually smaller as the infection heals, this study was intended to answer the question, as to whether this process can be made visible by the use of contrast media radiography, and whether this information could be used to determine when an irrigation therapy can safely be discontinued. In 1997, 34 patients suffered from sternal wound healing disturbances which required re-operation at our institution (incidence = 0.97%). During the re-operation, a closed retrosternal irrigation drainage was inserted. Of the 34 patients contrast media radiography examinations were carried out on the first, 4th and 12th postoperative day (POD), which consisted of an antero-posterior x-ray of the chest after contrast media injection through each inlet tube. At POD 4 and 12 in the majority of cases, the retrosternal irrigation cavity became smaller when compared with the previous x-ray examination. Only in three of the non-survivors there was a huge irrigation cavity visible at the 12th POD, which sometimes even included the pleural cavity. We conclude that in patients with mediastinitis treated by insertion of a closed irrigation drainage, the retrosternally irrigated cavity seems to become smaller over the therapeutic course of treatment. This process can be visualized by contrast media radiography. Results from this examination should be included in decision making about the best time for discontinuation of the irrigation therapy.
Department of Cardio-thoracic and Vascular Surgery, Deutsches Herzzentrum Berlin, Augustenburger Platz 1 D-13353, Berlin, Germany.
T
T
Krabatsch
R
R
Hetzer
D000891:Anti-Infective Agents, Local / Q000008:administration & dosage / Q000627:therapeutic use; D001021:Aortic Valve / Q000601:surgery; D003287:Contrast Media; D001026:Coronary Artery Bypass / Q000009:adverse effects; D003646:Debridement; D003657:Decision Making; D004322:Drainage; D005500:Follow-Up Studies; D019918:Heart Valve Prosthesis Implantation / Q000009:adverse effects; D006801:Humans; D007472:Iohexol / Q000031:analogs & derivatives*; D008480:Mediastinitis / Q000000981:diagnostic imaging* / Q000601:surgery; D008875:Middle Aged; D010994:Pleura / Q000000981:diagnostic imaging; D011206:Povidone-Iodine / Q000008:administration & dosage / Q000627:therapeutic use; D013902:Radiography, Thoracic; D012086:Reoperation; D013249:Sternum / Q000000981:diagnostic imaging* / Q000601:surgery; D013529:Surgical Wound Dehiscence / Q000000981:diagnostic imaging / Q000601:surgery; D013530:Surgical Wound Infection / Q000000981:diagnostic imaging* / Q000601:surgery; D007507:Therapeutic Irrigation
D000891:Anti-Infective Agents, Local; D003287:Contrast Media; D007472:Iohexol; C038192:iopromide; D011206:Povidone-Iodine